CHO Pharma, Inc. (TPEX:6586)
Taiwan
· Delayed Price · Currency is TWD 43.10
-1.40 (-3.15%)
Apr 24, 2025, 1:54 PM CST
CHO Pharma Revenue
In the year 2024, CHO Pharma had annual revenue of 3.58M TWD. CHO Pharma had revenue of 2.50M in the half year ending December 31, 2024, with 4,063.33% growth.
Revenue
3.58M
Revenue Growth
n/a
P/S Ratio
2,552.58
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.14B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.82B |
| Lumosa Therapeutics | 39.15M |